Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
09/27/2007 | US20070225291 Substituted Pyrazinone Compounds for the Treatment of Inflammation |
09/27/2007 | US20070225222 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
09/27/2007 | US20070225218 Extracellular Messengers |
09/27/2007 | US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
09/27/2007 | DE102006014165A1 Neue Isooxazol-Derivate und deren Verwendungen New isoxazole derivatives and uses thereof |
09/27/2007 | DE102006012875A1 Agent, useful e.g. for effective inhibition of platelet aggregation, comprises very long-chain fatty acid based on guerbet acid and/or crude montana wax or corresponding component of raw carnauba wax or shellack |
09/27/2007 | DE102006012671A1 Mittel zur Beeinflussung der Nozizeption und deren Folgen Means for influencing the nociception and its consequences |
09/27/2007 | CA2647779A1 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis |
09/27/2007 | CA2647020A1 Conjugated lipid derivatives |
09/27/2007 | CA2646958A1 Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
09/27/2007 | CA2646463A1 4-(pyrrolopyridinyl)pyrimidinyl-2-amine derivatives |
09/27/2007 | CA2646379A1 Method of treatment or prophylaxis inflammatory pain |
09/27/2007 | CA2646002A1 Salts with crth2 antagonist activity |
09/27/2007 | CA2645327A1 Use of (3s)-n-hydroxy-4-({4-[(4-hydroxy-2-butynyl)oxy]phenyl}sulfonyl)-2,2-dimethyl-3-thiomorpholine carboxamide or (s)-n-hydroxy-4-(4-but-2-ynyloxy-benzenesulfonyl) -2,2-dimethyl-thiomorpholine -3-carboxamide for treating inflammatory skin pathologies |
09/27/2007 | CA2644356A1 Heterocyclic organic compounds for the treatment of in particular melanoma |
09/26/2007 | EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
09/26/2007 | EP1836194A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
09/26/2007 | EP1836173A2 Anti-inflammatory medicaments |
09/26/2007 | EP1836160A1 Compounds for treating metabolic syndrome |
09/26/2007 | EP1835934A2 Enzyme modulators and treatments |
09/26/2007 | EP1835926A2 Plasmin-inhibitory therapies |
09/26/2007 | EP1835925A1 Method of reducing oral tissue inflammation using magnolia extract |
09/26/2007 | EP1835911A2 Therapeutic compositions for intranasal administration of ketorolac |
09/26/2007 | EP1835900A1 Sulfasalazine analogues as nf-kb inhibitors |
09/26/2007 | EP1559715B1 N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-n'-(5-methyl-3-isoxazolyl)urea salt in crystalline form |
09/26/2007 | EP1539755B1 6-alkoxy-pyrido-pyrimidines as p-38 map kinase inhibitors |
09/26/2007 | EP1490364B1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders |
09/26/2007 | EP1458708B1 Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5 |
09/26/2007 | EP1451153B1 Nk1 antagonists |
09/26/2007 | EP1438040B1 Pharmaceutical compositions comprising mycophenolic acid or mycophenolate salt |
09/26/2007 | EP1417173B1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
09/26/2007 | EP1417055A4 Use of copper chelators to inhibit the inactivation of protein c |
09/26/2007 | EP1414825B1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
09/26/2007 | EP1406873B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
09/26/2007 | EP1383750B1 Urea derivatives as integrin alpha 4 antagonists |
09/26/2007 | EP1374871B1 Crystalline isoxazole derivative and medical preparation thereof |
09/26/2007 | EP1303520B1 Therapeutic compounds and methods |
09/26/2007 | EP1302461B1 Tnf-alpha production inhibitors |
09/26/2007 | EP1265596B1 Medical emulsion for lubrication and delivery of drugs |
09/26/2007 | EP1261585B1 Substituted indole mannich bases |
09/26/2007 | EP1228046B1 Phthalazinone derivatives as pde 4 inhibitors |
09/26/2007 | CN200951202Y External use magnetic traditional Chinese medicine plaster for treating cervical vertebrae ache disease |
09/26/2007 | CN101044141A Purine derivatives for use as adenosin A-2A receptor agonists |
09/26/2007 | CN101044120A Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
09/26/2007 | CN101044116A 4-phenylsulfonamidopiperidines as calcium channel blockers |
09/26/2007 | CN101043907A Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract |
09/26/2007 | CN101043883A Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
09/26/2007 | CN101043822A Composition containing fermentable polysaccharides |
09/26/2007 | CN101041820A Macrophagocyte transfer inhibition factor monoclonal antibody and method for making same |
09/26/2007 | CN101041692A Scorpion analgesic antibacterial active peptide and preparation method thereof |
09/26/2007 | CN101041071A Interacted proteins of APC10 and the function for adjusting the cell period thereof |
09/26/2007 | CN101041065A Method for preparing Duyiwei compound injection |
09/26/2007 | CN101041054A Medicine for curing intractable rheumatic disease |
09/26/2007 | CN101041038A Chinese traditional medicine for treating Hanning Yangxu type dysmenorrhea |
09/26/2007 | CN101041036A Medicine liquid for reducing pain for external application |
09/26/2007 | CN101041030A Novel Bikang pill |
09/26/2007 | CN101041025A Pawpaw ferns sweet wine |
09/26/2007 | CN101041003A External-applied Chinese medicine for treating pain of waist and leg |
09/26/2007 | CN101040987A Medicine for treating fever after cesarean section |
09/26/2007 | CN101040981A Chinese traditional medicine compound took orally for treating cervical spondylotic radiculopathy |
09/26/2007 | CN101040974A Medicine for treating the pain of neck, shoulder, waist and leg |
09/26/2007 | CN101040972A Acetanilide for treating rheumatism disease and the preparing method |
09/26/2007 | CN101040969A Chinese medicine composition for treating rheumatism |
09/26/2007 | CN101040949A Medicine compound for creating rheumatism and rheumatoid arthritis and the preparing method and apllication |
09/26/2007 | CN101040939A Chinese traditional wine medicine for treating pain of neck, shoulder, waist and leg hamstring and the preparing method thereof |
09/26/2007 | CN101040938A Ganoerma lucidum anti-inflammatory detumescent compound agent |
09/26/2007 | CN101040930A Chinese traditional medicine for treating protrusion of lumbar intervertebral disc for external application |
09/26/2007 | CN101040927A Chinese traditional medicine compound took orally for treating ankylosing spondylitis |
09/26/2007 | CN101040910A Medicine for treating ankylosing spondylitis |
09/26/2007 | CN101040908A Chinese traditional medicine compound took orally for treating ankylosing spondylitis |
09/26/2007 | CN101040903A Farinfrared emplastrum |
09/26/2007 | CN101040891A Method of preparing tripterygium hypoglaucum (Levl) hutch alkaloids |
09/26/2007 | CN101040862A Application of gastrodin in the medicine for treating rheumatoid arthritis |
09/26/2007 | CN101040642A Ginger life cold tea and the method for preparing the same |
09/26/2007 | CN101040641A Thin leaf chrysanthemum tea |
09/26/2007 | CN101040640A Tea for treating fever and cough |
09/26/2007 | CN101040639A Tea for digesting food and good for stomach |
09/26/2007 | CN100339467C Technological process for producing scorpion wine |
09/26/2007 | CN100339394C 组织特异性表达 Tissue-specific expression |
09/26/2007 | CN100339376C Nitrogen-containing aromatic ring derivatives |
09/26/2007 | CN100339374C Compounds and methods for modulation of estrogen receptors |
09/26/2007 | CN100339102C Medicinal plaster for treating sinew and bone tissue injury pain, bone fracture, dislocation |
09/25/2007 | US7273952 Substituted C-cyclohexylmethylamine derivatives |
09/25/2007 | US7273889 Administering ketamine in mixture with carrier; side effect reduction |
09/25/2007 | US7273875 Blocking tumor necrosis factor; antiinflammatory agents; respiratory system disorders; bronchodilator |
09/25/2007 | US7273872 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages |
09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
09/25/2007 | US7273858 Salts |
09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
09/25/2007 | US7273744 Heparanase-like polypeptides |
09/25/2007 | US7273712 Methods and compositions for detecting compounds that modulate inflammatory responses |
09/25/2007 | US7273612 Soluble inhibitors of vascular endothelial growth factor and use thereof |
09/25/2007 | CA2547947C Azole derivatives as active superoxide radical inhibitors |
09/25/2007 | CA2294607C Use of gaba analogs such as gabapentin in the manufacture of a medicament for treating inflammatory diseases |
09/25/2007 | CA2200967C Pharmaceutical compositions |
09/20/2007 | WO2007106022A2 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof. |
09/20/2007 | WO2007105929A1 Synergistic pharmaceutical composition of tramadol and lysine clonixinate |
09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |